The largest database of trusted experimental protocols

S48 square pulse stimulator

Manufactured by Natus
Sourced in United States

The S48 Square Pulse Stimulator is a lab equipment used to generate square-wave electrical pulses. It can be used to provide controlled electrical stimulation in various experimental and research settings.

Automatically generated - may contain errors

7 protocols using s48 square pulse stimulator

1

6-Hz-induced Seizures in Mice: Anticonvulsant Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 6-Hz-induced psychomotor seizures in mice were evoked by current (6 Hz, 0.2 ms rectangular pulse width, 32 mA, 3 s duration) generated by an S48 Square Pulse Stimulator and CCU1 Constant Current Unit (Grass Technologies, West Warwick, RI, USA). The animals were administered with increasing doses of KA-228 and KA-232, and the anticonvulsant activity of each drug was evaluated as the ED50. This experimental procedure has been described in detail in our previous studies [19 (link),35 (link)].
+ Open protocol
+ Expand
2

Hippocampal Long-Term Potentiation Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
General population measurements of field excitatory postsynaptic potentials (fEPSP) were recorded with NaCl-filled (150 mM) glass micropipettes inserted into the stratum radiatum of the CA1 hippocampal subfield using a SUPER-Z head-stage attached to a BMA-931 AC/DC Bioamplifier (CWE-inc, Ardmore, PA, USA), Digidata1200 (Molecular Devices, Sunnyvale, CA, USA), and pClamp 9.0 software (Molecular Devices). Schaffer collaterals were electrically stimulated (0.3 ms constant current pulses) with bipolar tungsten electrodes using a S48 square pulse stimulator (GRASS technologies, Warwick, RI, USA). After slice recovery in the recording chamber (approximately 30 min), input–output curves relating stimulus current intensity to fEPSP slope and amplitude were generated. Stimulus intensity required for half-maximal fEPSP slope was selected. Paired-pulse experiments were performed using an intra-pulse duration of 50 ms. Stimulation for fEPSP was performed at a rate of 1 stimulus every 30 seconds for baseline recordings. Long-term potentiation (LTP) was then induced using tetanic stimulation (100 Hz) for 1 second. One minute following LTP, test stimulation (1 stimulus every 30 seconds) resumed for a period of 1 h and afterwards input–output curves were repeated. Slices from each animal were averaged together to give a n-value of one.
+ Open protocol
+ Expand
3

In situ Skeletal Muscle Contractile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Skeletal muscle contractile function was assessed in situ using a protocol adapted from Kalmar and Greensmith [21 (link)] and MacIntosh, Esau, Holash and Fletcher [22 ]. Animals were anesthetised with tribromoethanol (20 mg kg/100 g body mass i.p.) and the sciatic nerve was exposed and connected to a platinum electrode. The distal tendon of the tibialis anterioris was connected to a surgical silk suture, which was connected to a previously calibrated force transducer. The sciatic nerve was stimulated using an S48 square pulse stimulator (Grass®) and the contractile data were acquired and processed using a data acquisition system (Biopac Systems, USA; AcqKnowledge software, version 4.4). 0.5 V pulses were used to maximise motor unit recruitment. The stimulation protocol consisted of three successive steps separated by 60 s intervals: 1) Single twitch: 5 isolated pulses at 1 Hz, 200 ms duration; 2) Maximum tetanic force: one pulse train at 150 Hz, duration 300 ms; 3) Fatigue test: one pulse train per second at 40 Hz, with the duration of 333 ms for 3 min.
+ Open protocol
+ Expand
4

Corneal Stimulation-Induced Seizure Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seizure activity in mice was evoked by a current (6 Hz, 0.2 ms rectangular pulse width, 32 mA, 3 s duration) generated by an S48 Square Pulse Stimulator and CCU1 Constant Current Unit (Grass Technologies, West Warwick, RI, USA). After the application of an ocular anesthetic (0.5% solution of tetracaine hydrochloride) to the mouse corneas, the animals underwent corneal stimulation and were placed separately in Plexiglas cages (25 cm × 15 cm ×10 cm) for the observation of the presence or absence of psychomotor seizures, as described previously [15 (link),78 (link),79 (link)]. When the observation of 8 mice in the respective group was finished, the animals underwent euthanasia by CO2 narcosis. To determine median effective doses (ED50 values) of ASMs, the drugs were administered i.p. at the following doses: LCM: 2–10 mg/kg; LEV: 10–20 mg/kg; PB: 2–12 mg/kg and VPA: 50–150 mg/kg.
+ Open protocol
+ Expand
5

Anticonvulsant Screening of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments on animals were performed in accordance with EU Directive 2010/63/EU for animal experiments and complied with the ARRIVE guidelines. Ethics approval for animal experimentations was obtained from the Local Ethics Committee (Lublin, Poland, approval number: 65/2018). Psychomotor seizures in mice were evoked by current (6 Hz, 0.2 ms rectangular pulse width, 32 mA, 3 s duration) generated by an S48 Square Pulse Stimulator and CCU1 Constant Current Unit (Grass Technologies, West Warwick, RI, USA). After application of ophthalmic anaesthetic (0.5% tetracaine hydrochloride) to the mice corneas, the animals underwent corneal stimulation and were placed separately in plexiglas cages (25 × 15 × 10 cm) for the observation of the presence or absence of psychomotor seizures17 (link). The animals were administered with increasing doses of TP-10, TP-315, TP-427, and the anticonvulsant activity of each compound was evaluated as the ED50 value (median effective dose of the drug, which protects 50% of mice against convulsions) calculated using the log-probit method of Litchfield and Wilcoxon18 (link).
+ Open protocol
+ Expand
6

Suppressing Cortical Activity with Topical TTX

Check if the same lab product or an alternative is used in the 5 most similar protocols
To demonstrate the suppression of cortical evoked activity by topical TTX, animals were anesthetized (isoflurane in 30% O2 and 70% N2) and placed in a stereotaxic frame. An open cranial window was prepared over the right barrel cortex, 1.3 mm posterior and 3.6 mm lateral to bregma. A glass micropipette was placed on the exposed dura and extracellular SSEPs were recorded relative to an Ag/AgCl reference electrode placed subcutaneously in the neck. Cortical surface was kept moist by 0.9% NaCl solution. Signals were amplified (Axoprobe 1A, Axon Instruments) and digitized for offline analysis (Powerlab/16sp, ADinstruments). Contralateral whisker pad was stimulated in a bipolar fashion by needle electrodes 5 mm apart (700 μA, 150 μs square pulses at 0.1 Hz; A395 stimulus isolator, WPI triggered by an S48 square pulse stimulator, Grass technologies). After locating the maximal SSEP amplitude (~450 μm below dura), baseline SSEPs were recorded for 5 minutes, and TTX (1μM in 0.9% NaCl) was applied topically onto the recording window, and replenished during 30 minutes subsequent recording. SSEPs were averaged offline every 2 minutes and plotted over time.
+ Open protocol
+ Expand
7

Acute 6-Hz Seizure Model Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The acute 6-Hz seizure model was conducted as explained previously [30 (link)–32 (link)]. Corneal stimulation (0.2 ms rectangular pulses at 6 Hz for 3 s) was delivered by a constant-current device (CCU1) connected to an S48 Square Pulse Stimulator (Grass Technologies, West Warwick, RI, USA). A fixed current intensity of 32 mA was used to allow this data to be directly compared with data obtained in the aforementioned studies. Animals were randomly divided into three groups with ten animals in each group. Before stimulation, a drop of saline was applied to each eye to ensure optimal current conductivity. Seizures were characterized by a stunned or fixed posture often accompanied by rearing, forelimb clonus, and twitching. The duration of seizure activity was measured as the evaluation criterion for the protective effect of the compound. The animal was considered to be protected if it resumed its normal exploratory behavior within 7 s of the stimulation. In contrast, the compound had no protective effect if the above typical characteristic behaviors occurred in the animal after drug administration or if the duration of the seizure was longer than 7 s.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!